Uncertainty over obtaining a health-related functional claim
First written in FY2022-Q3. 6 of 7 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「Research into the blood-forming function of acai has elucidated the mechanisms involved in blood formation, and the Company aims ultimately to obtain a functional claim through clinical trials and further research into the relevant constituents. However, depending on the results of the clinical trials and research, it may not be possible to obtain the claim」
The Company continues to state its goal of researching the blood-forming function and obtaining a functional claim, as well as the uncertainty that the claim may not be obtained depending on the research results. - FY2025RestatedAnnual report
「Research into the blood-forming function of acai has elucidated the mechanisms involved in blood formation, and the Company aims ultimately to obtain a functional claim through clinical trials and further research into the relevant constituents. However, depending on the results of the clinical trials and research, it may not be possible to obtain the claim, which could affect the Company's business and performance.」
The Company continues to state its goal of researching the blood-forming function and obtaining a functional claim, as well as the uncertainty that the claim may not be obtained depending on the research results. - FY2025-H1RestatedAnnual report
「However, the measures aimed at improving sales and profitability in order to transform the Company into a sustainably profitable business will require a certain amount of time to take effect and will also be affected by future economic conditions. Accordingly, a material uncertainty related to the going concern assumption is recognized at present.」
The Company continues to explain that significant uncertainty remains because it is proceeding with measures to improve sales and profitability, while their effectiveness depends on the economic environment and other factors. - FY2024RestatedAnnual report
「Research into the blood-forming function of acai has elucidated the mechanisms involved in blood formation, and the Company aims ultimately to obtain a functional claim through clinical trials and further research into the relevant constituents. However, depending on the results of the clinical trials and research, it may not be possible to obtain the claim, which could affect the Company's business and performance.」
The Company continues to state both its goal of obtaining a functional claim following clinical trials and further research and the uncertainty that the claim may not be obtained depending on the research results. - FY2023-Q2RestatedAnnual report
「The Company is conducting research into the blood-forming function of acai, and the research is progressing smoothly.」
The Company continues its research into the blood-forming function and its efforts to obtain a functional claim, but does not state that the claim has been obtained or that the related uncertainty has been resolved. - FY2022RestatedAnnual report
「Research into the blood-forming function of acai, including planned clinical trials and further research into the relevant constituents, is progressing as planned, and the Company aims to obtain a functional claim.」
Research aimed at obtaining a functional claim is progressing, but the risk remains that the claim may not be obtained depending on the results of the clinical trials and further research. - FY2022-Q3First statedAnnual report
「Research into the blood-forming function of acai has elucidated the mechanisms involved in blood formation, and the Company aims ultimately to obtain a functional claim through clinical trials and further research into the relevant constituents. However, depending on the results of the clinical trials and research, it may not be possible to obtain the claim.」
The Company has, for the first time, explicitly identified as a separate risk the possibility that it may not obtain a functional claim, depending on the results of clinical trials and further research under its research plan.